OPEN END TURBO LONG - IPSEN | Market Closed - Börse Stuttgart 12:02:01 2024-06-14 pm EDT | ||
| 7.65 EUR | -3.16% |
|
| 1 month | -0.26% | ||
| 3 months | +19.34% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
| Date | Price | Change |
|---|---|---|
| 24-06-14 | 7.65 | -3.16% |
| 24-06-13 | 7.9 | -3.42% |
| 24-06-12 | 8.18 | +6.51% |
| 24-06-11 | 7.68 | -2.54% |
| 24-06-10 | 7.88 | -0.25% |
Delayed Quote Börse Stuttgart
Last update June 14, 2024 at 12:02 pm EDT
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | Morgan Stanley |
| WKN | MD5AFQ |
| ISIN | DE000MD5AFQ4 |
| Date issued | 2022-06-16 |
| Strike | 43.92 € |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 4.46 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 8.84 € |
|---|---|
| Lowest since issue | 4.01 € |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
120.5
EUR
Average target price
127.3
EUR
Spread / Average Target
+5.62%
- Stock Market
- Certificates
- Certificat
